4//SEC Filing
Lucchese Joseph 4
Accession 0001104659-22-047222
CIK 0001504167other
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 1:03 PM ET
Size
5.7 KB
Accession
0001104659-22-047222
Insider Transaction Report
Form 4
Lucchese Joseph
Executive VP & CFO
Transactions
- Award
Stock Option (right to buy)
2022-04-15+300,000→ 300,000 totalExercise: $0.31Exp: 2032-04-14→ Common Stock, par value $0.001 per share (300,000 underlying)
Footnotes (1)
- [F1]25% of the options vest on April 15, 2023, and the remaining shares will become exercisable in 36 equal monthly installments beginning on May 15, 2023, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date.
Documents
Issuer
Timber Pharmaceuticals, Inc.
CIK 0001504167
Entity typeother
Related Parties
1- filerCIK 0001810134
Filing Metadata
- Form type
- 4
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 1:03 PM ET
- Size
- 5.7 KB